Analysis of Radiation Pneumonitis Risk Using a Generalized Lyman Model

International Journal of Radiation Oncology Biology Physics

Volumn 72, Issue 2, 2008, Pages 568-574

  Tucker, Susan L ^a   Liu, H Helen ^a   Liao, Zhongxing ^a   Wei, Xiong ^a   Wang, Shulian ^b   Jin, Hekun ^c   Komaki, Ritsuko ^a   Martel, Mary K ^a   Mohan, Radhe ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b CANCER HOSPITAL   (China)

^c HUNAN CANCER HOSPITAL   (China)

Author keywords

Lung cancer; Lyman model; NTCP; Radiation pneumonitis; Smoking

Indexed keywords

BIOLOGICAL ORGANS; FORECASTING; PARAMETER ESTIMATION; PINCH EFFECT; RISK PERCEPTION; TOXICITY;

LUNG CANCER; LYMAN MODEL; NTCP; RADIATION PNEUMONITIS; SMOKING;

RISK ASSESSMENT;

ARTICLE; CIGARETTE SMOKING; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; DISEASE SEVERITY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MORBIDITY; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE; RADIATION PNEUMONIA; RISK FACTOR; SCORING SYSTEM; TREATMENT PLANNING;

CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG; LUNG NEOPLASMS; MODELS, STATISTICAL; PROBABILITY; RADIATION PNEUMONITIS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; RETROSPECTIVE STUDIES; SMOKING; TIME FACTORS;

EID: 51449099729     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.04.053     Document Type: Article

References (37)

1. Lyman J.T. Complication probability as assessed from dose-volume histograms. Radiat Res Suppl 8 (1985) S13-S19
2. Hernando M.L., Marks L.B., Bentel G.C., et al. Radiation-induced pulmonary toxicity: A dose-volume histogram analysis in 201 patients with lung cancer. Int J Radiat Oncol Biol Phys 51 (2001) 650-659
3. Kahan Z., Csenki M., Varga Z., et al. The risk of early and late lung sequelae after conformal radiotherapy in breast cancer patients. Int J Radiat Oncol Biol Phys 68 (2007) 673-681
4. Johansson S., Bjermer L., Franzen L., et al. Effects of ongoing smoking on the development of radiation-induced pneumonitis in breast cancer and oesophagus cancer patients. Radiother Oncol 49 (1998) 41-47
5. Berkson J., and Gage R.P. Survival curve for cancer patients following treatment. J Am Stat Assoc 47 (1952) 501-515
6. Farewell V.T. The use of mixture models for the analysis of survival data with long-term survivors. Biometrics 38 (1982) 1041-1046
7. Bentzen S.M., Thames H.D., Travis E.L., et al. Direct estimation of latent time for radiation injury in late-responding normal tissues: Gut, lung, and spinal cord. Int J Radiat Biol 55 (1989) 27-43
8. Schultheiss T.E., Thames H.D., Peters L.J., et al. Effect of latency on calculated complication rates. Int J Radiat Oncol Biol Phys 12 (1986) 1861-1865
9. Trotti A., Colevas A.D., Setser A., et al. CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 13 (2003) 176-181
10. Morgan B.J.T. Analysis of quantal response data (1992), Chapman & Hall, New York
11. Kutcher G.J., and Burman C. Calculation of complication probability factors for non-uniform normal tissue irradiation: The effective volume method. Int J Radiat Oncol Biol Phys 16 (1989) 1623-1630
12. Mohan R., Mageras G.S., Baldwin B., et al. Clinically relevant optimization of 3-D conformal treatments. Med Phys 19 (1992) 933-944
13. Kaplan E.L., and Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-481
14. Cox D.R. Regression models and life tables. J Royal Stat Soc B 34 (1972) 187-220
15. Farewell V.T. Mixture models in survival analysis: Are they worth the risk?. Can J Stat 14 (1986) 257-262
16. Taylor J.M., and Kim D.K. Statistical models for analysing time-to-occurrence data in radiobiology and radiation oncology. Int J Radiat Biol 64 (1993) 627-640
17. Li C., Taylor J.M.G., and Sy J.P. Identifiability of cure models. Stat Probability Lett 54 (2001) 389-395
18. Peeters S.T.H., Hoogeman M.S., Heemsbergen W.D., et al. Rectal bleeding, fecal incontinence, and high stool frequency after conformal radiotherapy for prostate cancer: Normal tissue complication probability modeling. Int J Radiat Oncol Biol Phys 66 (2006) 11-19
19. Efron B., and Tibshirani R.J. An introduction to the bootstrap (1998), Chapman & Hall/CRC, New York
20. Oetzel D., Schraube P., Hensley F., et al. Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis. Int J Radiat Oncol Biol Phys 33 (1995) 455-460
21. Kwa S.L., Theuws J.C., Wagenaar A., et al. Evaluation of two dose-volume histogram reduction models for the prediction of radiation pneumonitis. Radiother Oncol 48 (1998) 61-69
22. Yorke E.D., Jackson A., Rosenzweig K.E., et al. Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys 54 (2002) 329-339
23. Seppenwoolde Y., Lebesque J.V., de Jaeger K., et al. Comparing different NTCP models that predict the incidence of radiation pneumonitis. Normal tissue complication probability. Int J Radiat Oncol Biol Phys 55 (2003) 724-735
24. Chang D.T., Olivier K.R., Morris C.G., et al. The impact of heterogeneity correction on dosimetric parameters that predict for radiation pneumonitis. Int J Radiat Oncol Biol Phys 65 (2006) 125-131
25. Kong F.M., Hayman J.A., Griffith K.A., et al. Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): predictors for radiation pneumonitis and fibrosis. Int J Radiat Oncol Biol Phys 65 (2006) 1075-1086
26. Kwa S.L., Lebesque J.V., Theuws J.C., et al. Radiation pneumonitis as a function of mean lung dose: An analysis of pooled data of 540 patients. Int J Radiat Oncol Biol Phys 42 (1998) 1-9
27. Martel M.K., Ten Haken R.K., Hazuka M.B., et al. Dose-volume histogram and 3-D treatment planning evaluation of patients with pneumonitis. Int J Radiat Oncol Biol Phys 28 (1994) 575-581
28. Travis E.L., Liao Z.X., and Tucker S.L. Spatial heterogeneity of the volume effect for radiation pneumonitis in mouse lung. Int J Radiat Oncol Biol Phys 38 (1997) 1045-1054
29. Liao Z.X., Travis E.L., and Tucker S.L. Damage and morbidity from pneumonitis after irradiation of partial volumes of mouse lung. Int J Radiat Oncol Biol Phys 32 (1995) 1359-1370
30. Graham M.V., Purdy J.A., Emami B., et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 45 (1999) 323-329
31. Moiseenko V.V., Battista J.J., Hill R.P., et al. In-field and out-of-field effects in partial volume lung irradiation in rodents: Possible correlation between early DNA damage and functional endpoints. Int J Radiat Oncol Biol Phys 48 (2000) 1539-1548
32. Yorke E.D., Jackson A., Rosenzweig K.E., et al. Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study. Int J Radiat Oncol Biol Phys 63 (2005) 672-682
33. Seppenwoolde Y., De Jaeger K., Boersma L.J., et al. Regional differences in lung radiosensitivity after radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 60 (2004) 748-758
34. Yamada M., Kudoh S., Hirata K., et al. Risk factors of pneumonitis following chemoradiotherapy for lung cancer. Eur J Cancer 34 (1998) 71-75
35. Hope A.J., Lindsay P.E., El Naqa I., et al. Modeling radiation pneumonitis risk with clinical, dosimetric, and spatial parameters. Int J Radiat Oncol Biol Phys 65 (2006) 112-124
36. Rancati T., Ceresoli G.L., Gagliardi G., et al. Factors predicting radiation pneumonitis in lung cancer patients: A retrospective study. Radiother Oncol 67 (2003) 275-283
37. Morgan G.W., and Breit S.N. Radiation and the lung: A reevaluation of the mechanisms mediating pulmonary injury. Int J Radiat Oncol Biol Phys 31 (1995) 361-369